CytomX Therapeutics - 51 Year Dividend History | CTMX
Historical dividend payout and yield for CytomX Therapeutics (CTMX) since 1971. The current TTM dividend payout for CytomX Therapeutics (CTMX) as of January 20, 2022 is $0.00. The current dividend yield for CytomX Therapeutics as of January 20, 2022 is 0.00%.
||Medical - Biomedical and Genetics
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.